Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 3/20 | 0.42 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.39 |
| ▸ | FAAH | O00519 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.36 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27199095 | 1.00 | PSMB5 (0.42) | PSMB5SLC6A5NOD1PTPN1ITGB3 | |
| SCHEMBL17206101 | 0.93 | SLC6A5 (0.47) | SLC6A5NOD1PTPN1ITGB3ITGA2B | |
| SCHEMBL17206100 | 0.93 | SLC6A5 (0.47) | SLC6A5NOD1PTPN1ITGB3ITGA2B | |
| SCHEMBL23250521 | 0.92 | PLA2G2A (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B | |
| SCHEMBL27199092 | 0.92 | PLA2G2A (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B | |
| SCHEMBL23250556 | 0.92 | PLA2G2A (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B | |
| SCHEMBL29640354 | 0.88 | SLC6A5 (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B | |
| SCHEMBL29640332 | 0.88 | SLC6A5 (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B | |
| SCHEMBL30496934 | 0.88 | SLC6A5 (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B | |
| SCHEMBL30496953 | 0.88 | SLC6A5 (0.44) | PSMB5SLC6A5NOD1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4045033-A1 | N-ACYLATED HISTIDINE DIPEPTIDES AS ANTICANCER AGENTS | The Board of Trustees of the Leland Stanford Junior University (US) | 2022-08-24 | — | — | EP | claimed |